Article Sidebar

PDF
Date Published: 15/02/2023
Abstract Views: 181
Views PDF: 112
DOI: https://doi.org/10.51298/vmj.v521i2.4034
Issue
Vol. 521 No. 2 (2022)
Section
Các bài báo
How to Cite
Đỗ, M. H., Nguyễn, V. A. ., Vũ, M. T., Mai, V. T., & Phạm , Q. Đạo . (2023). OUTCOMES FOR STAGE I NON-SMALL CELL LUNG CANCER AT VIETNAM NATIONAL CANCER HOSPITAL. Vietnam Medical Journal, 521(2). https://doi.org/10.51298/vmj.v521i2.4034

OUTCOMES FOR STAGE I NON-SMALL CELL LUNG CANCER AT VIETNAM NATIONAL CANCER HOSPITAL

Mạnh Hùng Đỗ1,, Việt Anh Nguyễn1, Minh Tuấn Vũ1, Văn Tuấn Mai2, Quang Đạo Phạm 2
1 National Cancer Hospital
2 Hanoi Medical University

Main Article Content

Abstract

Background: This observational study evaluated the results of surgical treatment for patients with stage I non-small cell lung cancer (NSCLC). Methods: We retrospectively reviewed 103 patients with stage I NSCLC for January 2015 to May 2022 at Vietnam national cancer hospital were treated with surgery. The patients’ clinicopathological characteristics were reviewed and disease-free survival (DFS) time and overall survival time (OS) were estimated by the Kaplan-Meier method. Results: The overall complication rate was 8,7%, pneumonia was the most common. Three-year DFS and five-year DFS for patients with stage I were 86% and 71,5%, respectively. Medium DFS was 5,568 [95%CI: 5,075 – 6,061] years. Three-year OS and five-year OS for these patients were 92,2% and 80,2%, respectively. Medium OS was 5,952 [CI 95%: 5,543-6,361] years. There was no difference between the DFS, OS ratio at 3 years, 5 years of stage Ia compared to these of stage Ib (p= 0,972 và p=0,737). Conclusion: Surgical resection should be considered as the standard choice for stage I NSCLC.

Article Details

References

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi:https://doi.org/10.3322/caac.21660
2. Duma N, Santana-Davila R, Molina JR. Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019;94(8):1623-1640. doi:10.1016/j.mayocp.2019.01.013
3. Park BJ, Zhang H, Rusch VW, Amar D. Video-assisted thoracic surgery does not reduce the incidence of postoperative atrial fibrillation after pulmonary lobectomy. J Thorac Cardiovasc Surg. 2007;133(3):775-779. doi:10.1016/j.jtcvs.2006.09.022
4. Nguyễn Khắc Kiểm. Nghiên Cứu Nạo Vét Hạch Theo Bản Đồ Trong Phẫu Thuật Điều Trị Ung Thư Phổi Không Tế Bào Nhỏ Giai Đoạn I-II-IIIA. Luận Văn Tiến sĩ Y học. Trường Đại học Y Hà Nội; 2016.
5. Landreneau RJ, Normolle DP, Christie NA, et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(23):2449-2455. doi:10.1200/JCO.2013.50.8762
6. Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. 2009;115(22):5218-5227. doi:10.1002/ cncr.24625
7. Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(31):5043-5051. doi:10.1200/ JCO.2008.16.4855